最新报道:WindTree Therapeutics, a biopharmaceutical company, is reportedly considering holding a significant portion of its treasury reserves in Binance Coin (BNB) as part of its institutional crypto strategy. The firm aims to diversify its financial assets by exploring digital currencies, with BNB emerging as a potential candidate due to its utility and market stability. This move reflects a growing trend among corporations to integrate cryptocurrencies into treasury management for potential yield generation and hedging against traditional market volatility. WindTree's decision could signal broader institutional adoption of crypto assets in corporate finance strategies.